Research ExplorerPublicationsSeminal fluid ribavirin level and functional semen parameter...

Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.

Standard

Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy. / Hofer, Harald; Donnerer, Josef; Sator, Kathrin; Staufer, Katharina; Scherzer, Thomas-Matthias; Dejaco, Clemens; Sator, Michael; Kessler, Harald; Ferenci, Peter.

In: J HEPATOL, Vol. 52, No. 6, 6, 2010, p. 812-816.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Hofer, H, Donnerer, J, Sator, K, Staufer, K, Scherzer, T-M, Dejaco, C, Sator, M, Kessler, H & Ferenci, P 2010, 'Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.', J HEPATOL, vol. 52, no. 6, 6, pp. 812-816. <http://www.ncbi.nlm.nih.gov/pubmed/20399525?dopt=Citation>

APA

Hofer, H., Donnerer, J., Sator, K., Staufer, K., Scherzer, T-M., Dejaco, C., Sator, M., Kessler, H., & Ferenci, P. (2010). Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy. J HEPATOL, 52(6), 812-816. [6]. http://www.ncbi.nlm.nih.gov/pubmed/20399525?dopt=Citation

Vancouver

Hofer H, Donnerer J, Sator K, Staufer K, Scherzer T-M, Dejaco C et al. Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy. J HEPATOL. 2010;52(6):812-816. 6.

Bibtex

@article{5063a9fddc01440f961269196e921ed4,
title = "Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.",
abstract = "Due to the possible teratogenic effect of ribavirin, effective contraception is mandatory during antiviral therapy in patients with chronic hepatitis C (CHC). The aim of this study was to evaluate seminal parameters and ribavirin and HCV-RNA concentrations in seminal fluid and serum prior to and during antiviral treatment.",
keywords = "Adult, Humans, Male, Middle Aged, dosage, Hepatitis C, Chronic drug therapy, Antiviral Agents administration, Asthenozoospermia chemically induced, Drug Therapy, Combination, Hepacivirus genetics, Interferon Alfa-2a administration, Oligospermia chemically induced, RNA, Viral metabolism, Ribavirin administration, Semen metabolism, Spermatogenesis drug effects, Spermatozoa drug effects, Adult, Humans, Male, Middle Aged, dosage, Hepatitis C, Chronic drug therapy, Antiviral Agents administration, Asthenozoospermia chemically induced, Drug Therapy, Combination, Hepacivirus genetics, Interferon Alfa-2a administration, Oligospermia chemically induced, RNA, Viral metabolism, Ribavirin administration, Semen metabolism, Spermatogenesis drug effects, Spermatozoa drug effects",
author = "Harald Hofer and Josef Donnerer and Kathrin Sator and Katharina Staufer and Thomas-Matthias Scherzer and Clemens Dejaco and Michael Sator and Harald Kessler and Peter Ferenci",
year = "2010",
language = "Deutsch",
volume = "52",
pages = "812--816",
journal = "J HEPATOL",
issn = "0168-8278",
publisher = "Elsevier",
number = "6",

}

RIS

TY - JOUR

T1 - Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.

AU - Hofer, Harald

AU - Donnerer, Josef

AU - Sator, Kathrin

AU - Staufer, Katharina

AU - Scherzer, Thomas-Matthias

AU - Dejaco, Clemens

AU - Sator, Michael

AU - Kessler, Harald

AU - Ferenci, Peter

PY - 2010

Y1 - 2010

N2 - Due to the possible teratogenic effect of ribavirin, effective contraception is mandatory during antiviral therapy in patients with chronic hepatitis C (CHC). The aim of this study was to evaluate seminal parameters and ribavirin and HCV-RNA concentrations in seminal fluid and serum prior to and during antiviral treatment.

AB - Due to the possible teratogenic effect of ribavirin, effective contraception is mandatory during antiviral therapy in patients with chronic hepatitis C (CHC). The aim of this study was to evaluate seminal parameters and ribavirin and HCV-RNA concentrations in seminal fluid and serum prior to and during antiviral treatment.

KW - Adult

KW - Humans

KW - Male

KW - Middle Aged

KW - dosage

KW - Hepatitis C, Chronic drug therapy

KW - Antiviral Agents administration

KW - Asthenozoospermia chemically induced

KW - Drug Therapy, Combination

KW - Hepacivirus genetics

KW - Interferon Alfa-2a administration

KW - Oligospermia chemically induced

KW - RNA, Viral metabolism

KW - Ribavirin administration

KW - Semen metabolism

KW - Spermatogenesis drug effects

KW - Spermatozoa drug effects

KW - Adult

KW - Humans

KW - Male

KW - Middle Aged

KW - dosage

KW - Hepatitis C, Chronic drug therapy

KW - Antiviral Agents administration

KW - Asthenozoospermia chemically induced

KW - Drug Therapy, Combination

KW - Hepacivirus genetics

KW - Interferon Alfa-2a administration

KW - Oligospermia chemically induced

KW - RNA, Viral metabolism

KW - Ribavirin administration

KW - Semen metabolism

KW - Spermatogenesis drug effects

KW - Spermatozoa drug effects

M3 - SCORING: Zeitschriftenaufsatz

VL - 52

SP - 812

EP - 816

JO - J HEPATOL

JF - J HEPATOL

SN - 0168-8278

IS - 6

M1 - 6

ER -